Donna L. Dehn - Concepedia

Author

Donna L. Dehn

University of Colorado Denver

Also Known As

Dehn, D.L., Donna Dehn, Donna L Dehn, Donna L. Dehn

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver University of Colorado Health University of Nottingham University of Exeter

About

Donna L. Dehn is an author at University of Colorado Denver specializing in tumor biology, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	192
2	Health Sciences	1	1	78
3	Natural Sciences	1	1	83
4	Biochemistry	1	1	83
5	Chemical Biology	1	1	83

Donna L. Dehn

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
NAD(P)H:Quinone Oxidoreductase 1: Role as a Superoxide Scavenger David Siegel, Daniel L. Gustafson, Donna L. Dehn, Molecular Pharmacology	2004	444
Interaction of Human NAD(P)H:Quinone Oxidoreductase 1 (NQO1) with the Tumor Suppressor Protein p53 in Cells and Cell-free Systems Adil Anwar, Donna L. Dehn, David Siegel, Journal of Biological Chemistry	2003	135
B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration Takashi Miyatake, Barbara Tringler, Wenhui Liu, Gynecologic Oncology Tumor BiologyEndometrioid AdenocarcinomasTumoral PathologyMedicineGynecology	2007	114
Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90 Russell R. A. Kitson, Chuan‐Hsin Chang, Rui Xiong, Nature Chemistry BiochemistryNatural SciencesMolecular Biology19-Substituted GeldanamycinsShock Protein Hsp90	2013	83
Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones 1 2 1In accordance with the policy of the University of Colorado Health Sciences Center, D.R., R.H.J.H., and J.B. declare a patent interest in RH1. 2Abbreviations: MMC, mitomycin C; NQO1, NAD(P)H:quinone oxidoreductase 1 or DT-diaphorase; MeDZQ, 2,5-diaziridinyl-3,6-dimethyl-1,4-benzoquinone; DCPIP, 2,6-dichlorophenol-indophenol; MTT, thiazolyl blue; P450R, NADPH:cytochrome P450 reductase; b5R, NADH:cytochrome b5 reductase; NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; FBS, fetal bovine serum; and MEM, Eagle’s minimum essential medium. Shannon L. Winski, Elizabeth Swann, Robert H. J. Hargreaves, Biochemical Pharmacology	2001	83
NQO1 Expression in Pancreatic Cancer and Its Potential Use as a Biomarker Nida S. Awadallah, Donna L. Dehn, Raj J. Shah, Applied immunohistochemistry & molecular morphology Surgical OncologyMolecular MarkersPotential UsePathologyCancer Biology	2008	78
Biochemical, Cytotoxic, and Genotoxic Effects of ES936, a Mechanism-Based Inhibitor of NAD(P)H:quinone Oxidoreductase 1, in Cellular Systems Donna L. Dehn, David Siegel, Elizabeth Swann, Molecular Pharmacology	2003	54
p16<sup>INK4a</sup> is superior to high‐risk human papillomavirus testing in cervical cytology for the prediction of underlying high‐grade dysplasia Panduka Samarawardana, Donna L. Dehn, Meenakshi Singh, Cancer Cytopathology	2010	47
5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer <i>in vitro</i> and <i>in vivo</i> Donna L. Dehn, David Siegel, Khan Shoeb Zafar, Molecular Cancer Therapeutics	2006	41
Nicotine and Cotinine Adducts of a Melanin Intermediate Demonstrated by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Donna L. Dehn, David J. Claffey, Mark W. Duncan, Chemical Research in Toxicology	2001	37

Page 1